251. DiscipleShift
4,872 results on '"Harrington, Robert"'
Search Results
252. COVID-19 at 1 Year
253. Tenofovir-Associated Decline in Renal Function
254. Letters to the Editor
255. ACCF/AHA 2011 Health Policy Statement on Therapeutic Interchange and Substitution: A Report of the American College of Cardiology Foundation Clinical Quality Committee
256. The Incidence of Bradyarrhythmias and Clinical Bradyarrhythmic Events in Patients With Acute Coronary Syndromes Treated With Ticagrelor or Clopidogrel in the PLATO (Platelet Inhibition and Patient Outcomes) Trial: Results of the Continuous Electrocardiographic Assessment Substudy
257. ACCF/AHA 2011 Expert Consensus Document on Hypertension in the Elderly: A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents Developed in Collaboration With the American Academy of Neurology, American Geriatrics Society, American Society for Preventive Cardiology, American Society of Hypertension, American Society of Nephrology, Association of Black Cardiologists, and European Society of Hypertension
258. Cytokine antibody array analysis in brain and periphery of scrapie-infected Tg338 mice
259. Pulmonary Function in Patients With Acute Coronary Syndrome Treated With Ticagrelor or Clopidogrel (from the Platelet Inhibition and Patient Outcomes [PLATO] Pulmonary Function Substudy)
260. PrPres in placental tissue following experimental transmission of atypical scrapie in ARR/ARR sheep is not infectious by Tg338 mouse bioassay
261. Extraction and Detection of Geosmin and 2-Methylisoborneol in Water Using High-Capacity Sorptive Extraction (HiSorb tm) with Analysis by GC–MS
262. The Impact of Sustainability and Leadership on the Innovation Management of Michelin-Starred Chefs
263. Ischemic Events Occur Early in Patients Undergoing Percutaneous Coronary Intervention and Are Reduced With Cangrelor: Findings From CHAMPION PHOENIX
264. The Pivotal Role of Women in Cardiology Sections in Medical Organizations: From Leadership Training to Personal Enrichment
265. Abstract 13221: The Biomarker-Based ABC-ACS (Age, Biomarkers, Clinical History) Score Can Predict Major Bleeding Better Than Other Contemporary Scores in Patients on Dual Antiplatelet Therapy After Coronary Revascularization: Results of a Large Derivation and Validation Study
266. Abstract 14274: Machine Learning-Enhanced Determinants of Oral Anticoagulation in Atrial Fibrillation: Findings From the PINNACLE Registry
267. Abstract 9515: Heterogeneity of Benefit on Quality of Life With an Invasive versus Conservative Strategy for Chronic Coronary Disease. Results From the ISCHEMIA Trial
268. HIV Infection and Antiretroviral Therapy: Effect on Hepatitis C Virus Quasispecies Variability
269. The TAMI Trials
270. Letters to the Editor
271. Tooth loss is independently associated with poor outcomes in stable coronary heart disease
272. Safety and efficacy of ticagrelor and clopidogrel in primary percutaneous coronary intervention
273. The effect of cangrelor and access site on ischaemic and bleeding events: insights from CHAMPION PHOENIX
274. High-degree atrioventricular block, asystole, and electro-mechanical dissociation complicating non–ST-segment elevation myocardial infarction
275. Relationship between postoperative clopidogrel use and subsequent angiographic and clinical outcomes following coronary artery bypass grafting
276. EPC mobilization after erythropoietin treatment in acute ST-elevation myocardial infarction: the REVEAL EPC substudy
277. Appropriate Use Criteria for Coronary Revascularization and the Learning Health System: A Good Start
278. Of Mice and Men
279. Relapse of Secondary Syphilis After Benzathine Penicillin G: Molecular Analysis
280. Private Equity in Medicine: Cardiology in the Crosshairs | MDedge.
281. Relationship between renal function and outcomes in high-risk patients with non-ST-segment elevation acute coronary syndromes: Results from SYNERGY
282. Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study
283. Impact of Recovery of Renal Function on Long-Term Mortality After Coronary Artery Bypass Grafting
284. Patterns of discharge antiplatelet therapy and late outcomes among 8,582 patients with bleeding during acute coronary syndrome: A pooled analysis from PURSUIT, PARAGON-A, PARAGON-B, and SYNERGY
285. Association between Immune Recovery Uveitis and a Diverse Intraocular Cytomegalovirus-Specific Cytotoxic T Cell Response
286. Using Aggregate Patient Data at the Bedside via an On-Demand Consultation Service
287. The Role of Organizational Factors on Employee Engagement and Hospitality Service Co-creation
288. The Compatibility between State Eligibility Criteria for Developmental Delays and Available Early Childhood Assessment Instrumentation.
289. The Relationship between the Woodcock-Johnson Psycho-Educational Battery-Revised (Early Development) and the Wechsler Preschool and Primary Scale of Intelligence-Revised.
290. Enoxaparin Versus Unfractionated Heparin in Elective Percutaneous Coronary Intervention: 1-Year Results From the STEEPLE (SafeTy and Efficacy of Enoxaparin in Percutaneous coronary intervention patients, an internationaL randomized Evaluation) Trial
291. Characterising and predicting bleeding in high-risk patients with an acute coronary syndrome
292. Comparison of quality-of-life measures after radial versus femoral artery access for cardiac catheterization in women: Results of the Study of Access Site for Enhancement of Percutaneous Coronary Intervention for Women quality-of-life substudy
293. The future of cardiovascular clinical research in North America and beyond—addressing challenges and leveraging opportunities through unique academic and grassroots collaborations
294. Anticoagulant therapy and outcomes in patients with prior or acute heart failure and acute coronary syndromes: Insights from the APixaban for PRevention of Acute ISchemic Events 2 trial
295. Selecting Revascularization Strategies in Patients with Coronary Disease
296. Recognition of biomarker identified high-risk patients in the Acute Medically Ill Venous Thromboembolism Prevention with Extended Duration Betrixaban study resulting in a protocol amendment
297. Systematic adjudication of myocardial infarction end-points in an international clinical trial
298. Disagreements between central clinical events committee and site investigator assessments of myocardial infarction endpoints in an international clinical trial: review of the PURSUIT study
299. Safety and tolerability of SCH 530348 in patients undergoing non-urgent percutaneous coronary intervention: a randomised, double-blind, placebo-controlled phase II study
300. Safety and feasibility of adjunctive antiplatelet therapy with intravenous elinogrel, a direct-acting and reversible P2Y12 ADP-receptor antagonist, before primary percutaneous intervention in patients with ST-elevation myocardial infarction: The Early Rapid ReversAl of Platelet ThromboSis with Intravenous Elinogrel before PCI to Optimize REperfusion in Acute Myocardial Infarction (ERASE MI) pilot trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.